NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases

Br J Haematol. 1999 Dec;107(3):674-6. doi: 10.1046/j.1365-2141.1999.01730.x.

Abstract

Expression of NG2 has been reported in the majority of paediatric acute leukaemia (AL) cases with MLL rearrangement. We demonstrated 7. 1 positivity in 2/3 paediatric and 4/11 adult MLL rearranged acute myeloid leukaemia (AML) but in 0/28 adult AML without MLL rearrangement, thus extending the 100% specificity to adult cases. Positivity correlated with stage of maturation arrest since it was found in 0/6 immature AML but in 6/8 monoblastic cases. These data demonstrate that, if NG2 expression in AL is the (in)direct result of MLL rearrangement, such activation is restricted to a monoblastic population in AML. They also have practical implications for NG2 diagnostic screening strategies.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Antigens / genetics*
  • Antigens / metabolism
  • Child, Preschool
  • DNA-Binding Proteins / genetics*
  • Gene Rearrangement
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Immunophenotyping
  • Leukemia, Myeloid / genetics*
  • Leukemia, Myeloid / immunology
  • Middle Aged
  • Myeloid-Lymphoid Leukemia Protein
  • Proteoglycans / genetics*
  • Proteoglycans / metabolism
  • Proto-Oncogenes*
  • Transcription Factors*
  • Tumor Cells, Cultured

Substances

  • Antigens
  • DNA-Binding Proteins
  • KMT2A protein, human
  • Proteoglycans
  • Transcription Factors
  • chondroitin sulfate proteoglycan 4
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase